Clinical Trial Update: ACT-GLOBAL THROMBOLYSIS (ACT-WHEN-001) Domain Within the ACT-GLOBAL Adaptive Platform Trial-NCT06352632 [Phase 3]

View source ↗

Summary

This source provides a Phase 3 ACT-GLOBAL trial update (ACT-WHEN-001) evaluating thrombolysis for acute ischemic stroke, with recruitment ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Snippet

Sponsor: University of Calgary | Conditions: Acute Ischemic Stroke AIS, Stroke Acute | Phase 3 | Status: RECRUITING